Health-Technology Holding · Dubai, UAE

The layer between diagnosis and longevity.

Diagnoz Dubai builds and operates companies at the frontier of preventive health. One detects the present state of the body. One changes its trajectory. Together they turn biological signals into decisions people can act on.

The Thesis, In One Line

Two companies, one continuum — from knowing your body to improving it.

The health continuum
01 · Detect
Diagnoz.AI
Understand your current state. AI that surfaces risk and disease earlier.
02 · Extend
BioAge
Change your trajectory. A measurable protocol to understand and improve biological age.
Present state Future trajectory
Portfolio

Wholly owned, actively operated.

Diagnoz Dubai is an owner–operator, not a passive investor. We hold the companies, shape the strategy, and share infrastructure across data, AI, and clinical rigor.

AI Diagnostics Held by Diagnoz Dubai
Diagnoz.AI
Detection · Clinical Intelligence

AI-driven diagnostic intelligence that helps surface disease earlier and supports clinical decisions with speed and precision — turning complex medical data into clear signals.

  • Earlier detection from clinical and biological data
  • Decision support built for medical settings
  • Designed around accuracy, speed, and trust
diagnoz.ai Operating
Longevity Held by Diagnoz Dubai
BioAge
Trajectory · Longevity Protocol

A measurable protocol for biological age. BioAge combines diagnostics, AI analysis, and personalized supplementation to help people read — and improve — how they age.

  • Biological age made measurable and legible
  • Personalized, data-guided supplementation
  • A protocol built to compound over time
bioage.care Pre-launch · Waitlist
Leadership

The founder behind both companies.

Diagnoz Dubai is led by a single operating vision — one founder who conceived, built, and connects the portfolio across diagnosis and longevity.

Dr. Adnan El Bakri, Founder and Chairman of Diagnoz Dubai Dr. Adnan El Bakri — Founder & Chairman
MDGeneral Surgery · Université de Reims
MScArtificial Intelligence · Paris-Saclay
MBAEntrepreneurship · HEC Paris
PatentWO2024002654 · Medical AI
Founder & Chairman

Dr. Adnan El Bakri

MD, MSc · Physician · Entrepreneur · AI Researcher

A Franco-Lebanese physician, urologic surgeon, and entrepreneur, Dr. El Bakri has spent more than fifteen years building at the intersection of medicine, artificial intelligence, and digital health — the exact ground on which Diagnoz Dubai's companies operate.

Born and raised in Tripoli, Lebanon, in a neighborhood marked by poverty and war, he trained at the Faculties of Medicine of Marseille and Reims and earned a Doctorate in Medicine alongside advanced studies in technological sciences, with the highest academic honors. His work bridging health and technology led to his naturalization on merit by the President of the French Republic.

He is a serial founder in health technology. His first venture, PassCare, pioneered a new model for sharing medical data — reaching a €30M valuation before a successful exit — and later helped inspire France's national digital health platform. Today he leads Diagnoz.AI, a European biotech building digital body twins through generative AI, now preparing a $100M Series A to scale its research and global expansion.

15+
Years bridging
health & tech
3
Ventures
founded
$100M
Series A
in preparation
3
Books
published
Recognition
Choiseul Top 100 — French leaders under 40 Innovation Award — CES Las Vegas French National Academy of Surgery Decorated · French Republican Guard Founder — National Council of e-Health, France Universal League of Public Good (UN · UNESCO)
Why This Portfolio

The value in health is moving upstream.

Both companies are built on the same conviction: the future of medicine is measured, predicted, and prevented — not just treated. We back that shift with capital and hands-on operating.

01

Measurement first

You cannot improve what you cannot see. Every company we hold starts by making an invisible signal — disease risk, biological age — clear and quantifiable.

02

AI as the engine

Data alone is noise. We use artificial intelligence to translate raw biological and clinical signals into decisions a person or a physician can actually act on.

03

Prevention over treatment

The largest gains in health and cost sit upstream. Detecting earlier and extending healthspan is where the science — and the market — is heading.

Headquarters

Built in Dubai, by design.

Dubai is not an address of convenience. It is the natural meeting point for the capital, talent, and regulatory momentum that health technology needs — and a gateway between Europe, MENA, and Asia.

  • RegulationProgressive health-innovation frameworks and a regulator building for the future of medicine.
  • CapitalDirect access to sovereign, institutional, and private capital focused on health and deep tech.
  • GatewayA single hub bridging European clinical rigor with fast-growing MENA and Asian demand.
  • TalentA magnet for medical, AI, and operating talent relocating to the region.

Portfolio footprint

Live demand across BioAge's waitlist markets
United Arab Emirates
MENA
Saudi Arabia
MENA
Lebanon
MENA
Morocco · Egypt
MENA / Africa
France · Belgium
Europe
Switzerland · UK
Europe
Netherlands
Europe
Europe MENA & Africa
Operating Model

One shared engine, two products.

  • 01

    Measure

    Capture the biological and clinical signal at the source.

  • 02

    Understand

    AI translates raw data into risk, scores, and clear priorities.

  • 03

    Act

    Detection informs a decision; a protocol informs an intervention.

  • 04

    Improve

    Re-measure, compound the gains, and feed the loop again.

Investor & Partnership Relations

Building the infrastructure of preventive health.

For investment, partnership, or portfolio inquiries, our team is available directly.

Investor relations ir@diagnozdubai.com
Headquarters Dubai, United Arab Emirates